Search filters

Filters
Clear All

Phase

  • 18
  • 63
  • 42
  • 80
  • 13
  • 93
  • 13
  • 581
  • 934
  • 404
  • 12
  • 45
  • 881
  • 931
  • 7
  • 20
  • 918

Found 938 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
HF-POLARIS
18 years - 99 years
All genders
Phase 3
This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced Ejection Fraction (HFmrEF) and excess body weight when compared to placebo. 
18 years or above
All genders
Phase 1
Interventional
This study investigates the investigational medication in patients with relapsed or refractory T-cell lymphoma. The purpose of this study is to understand how the medication works in the body and its effects on the disease.The study evaluates the safety and tolerability of the investigational medication. Researchers are also looking at …
18 years - 74 years
All genders
Phase 1
Interventional
This study investigates head and neck squamous cell carcinoma. The purpose of this study is to evaluate the safety and effectiveness of an investigational medication when used with standard chemotherapy and radiation therapy.The study focuses on assessing how well the investigational medication works with chemoradiation therapy. It evaluates the treatment's …
18 years or above
All genders
Phase 2
Interventional
This study investigates primary central nervous system lymphoma. The purpose of this study is to evaluate the safety and efficacy of an investigational medication as a first-line treatment for individuals who cannot undergo a transplant.The study evaluates the effectiveness and safety of the investigational medication in patients. It focuses on …
18 years or above
All genders
Phase 2
Interventional
This study investigates advanced renal cell carcinoma.The study evaluates the safety and tolerability of investigational medications in patients with this condition.Who can participate: Adults aged 18 or older with a confirmed diagnosis of RCC and no prior systemic therapy for RCC may participate. Participants must have adequate organ function and …
18 years or above
All genders
Phase 1/2
Interventional
The purpose of this study is to investigate locally advanced or metastatic estrogen receptor-positive, HER2-negative breast cancer. This study investigates how the investigational medication performs alone and when combined with another treatment.This study evaluates the safety and how well the investigational medication works. It looks at how the investigational medication …
99 years or below
All genders
This is a retrospective cohort study which primarily aims to understand if a patients UGT1A1 phenotype affects patients' clinical outcomes following treatment with sacitizumab. Patients will be consented for prospective sample collection to perform genotyping. The genotyping will be performed in a research laboratory and will not be returned to …
99 years or below
All genders
This is a prospective, multicenter, single-arm, open-label study to assess the long-term safety and effectiveness of AltavivaTM system for treatment of urinary incontinence (UUI).
18 years or above
All genders
Phase 2/3
Interventional
This study investigates neuroendocrine tumors. It focuses on participants who have previously received treatment for tumors that cannot be removed by surgery or have spread to other parts of the body.This study evaluates the effectiveness of an investigational medication compared to everolimus. It examines how well the treatments work and …
18 years or above
All genders
Observational
This study investigates spinal and sacral chordoma. It focuses on the effects of neoadjuvant radiation therapy, including proton therapy and stereotactic body radiation therapy, on circulating tumor DNA (ctDNA) and imaging changes.The study evaluates if biomarkers can be used to understand changes after radiation therapy. It looks at ctDNA levels …
901 - 910 of 938